Novel use of peptide compounds for treating muscle pain

Details for Australian Patent Application No. 2006281591 (hide)

Owner Schwarz Pharma AG

Inventors Stohr, Thomas; Beyreuther, Bettina

Agent Davies Collison Cave

Pub. Number AU-A-2006281591

PCT Pub. Number WO2007/020103

Priority 05017977.9 18.08.05 EP; 60/811,859 08.06.06 US; 60/811,840 08.06.06 US

Filing date 18 August 2006

Wipo publication date 22 February 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/020103 Priority application(s): WO2007/020103

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281594-Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors

2006281575-Method of producing a balloon of a balloon catheter